Stay updated on Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The record history shows a new revision entry (v3.5.4) and removes the previous revision (v3.5.3), updating the version sequence in the history.
    Difference
    0.1%
    Check dated 2026-05-15T05:40:55.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page’s platform revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a general software release with no apparent change to the displayed clinical trial record details.
    Difference
    0.1%
    Check dated 2026-04-23T22:08:14.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.2, was added to the history and the older v3.5.0 entry was removed.
    Difference
    0.1%
    Check dated 2026-04-16T18:22:11.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added version v3.5.0 to the history and removed version v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:28:54.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    A new Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the page history.
    Difference
    0.1%
    Check dated 2026-03-11T17:14:43.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    Added a new revision entry (v3.4.2) and removed an older notice about government funding/operating status (v3.4.1) from the history page.
    Difference
    0.4%
    Check dated 2026-02-11T01:47:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.